News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,912 Results
Type
Article (42061)
Company Profile (334)
Press Release (665517)
Section
Business (210199)
Career Advice (2085)
Deals (36587)
Drug Delivery (100)
Drug Development (82869)
Employer Resources (171)
FDA (16491)
Job Trends (15370)
News (355571)
Policy (33861)
Tag
Academia (2577)
Alliances (51199)
Alzheimer's disease (1280)
Approvals (16454)
Artificial intelligence (159)
Bankruptcy (362)
Best Places to Work (11725)
Biotechnology (216)
Breast cancer (193)
Cancer (1402)
Cardiovascular disease (116)
Career advice (1745)
Cell therapy (286)
Clinical research (66264)
Collaboration (499)
Compensation (267)
COVID-19 (2614)
C-suite (111)
Data (1406)
Diabetes (179)
Diagnostics (6256)
Earnings (86581)
Employer resources (149)
Events (112890)
Executive appointments (405)
FDA (17192)
Funding (440)
Gene therapy (207)
GLP-1 (634)
Government (4456)
Healthcare (18885)
Infectious disease (2707)
Inflammatory bowel disease (115)
Interviews (321)
IPO (16626)
Job creations (4053)
Job search strategy (1492)
Layoffs (439)
Legal (8343)
Lung cancer (200)
Lymphoma (100)
Manufacturing (216)
Medical device (13302)
Medtech (13307)
Mergers & acquisitions (20125)
Metabolic disorders (479)
Neuroscience (1614)
NextGen Class of 2024 (6631)
Non-profit (4515)
Northern California (1713)
Obesity (272)
Opinion (207)
Patents (124)
People (58436)
Phase I (20526)
Phase II (29156)
Phase III (21864)
Pipeline (517)
Postmarket research (2653)
Preclinical (8731)
Radiopharmaceuticals (241)
Rare diseases (276)
Real estate (6245)
Regulatory (22545)
Research institute (2361)
Resumes & cover letters (358)
Southern California (1480)
Startups (3712)
United States (15455)
Vaccines (584)
Weight loss (197)
Date
Today (12)
Last 7 days (177)
Last 30 days (2090)
Last 365 days (35763)
2024 (35732)
2023 (40631)
2022 (51803)
2021 (56334)
2020 (54804)
2019 (47431)
2018 (35788)
2017 (33147)
2016 (32680)
2015 (38629)
2014 (32523)
2013 (27646)
2012 (29747)
2011 (30500)
2010 (28513)
Location
Africa (780)
Arizona (203)
Asia (40192)
Australia (6430)
California (3866)
Canada (1467)
China (318)
Colorado (176)
Connecticut (181)
Europe (85542)
Florida (540)
Georgia (136)
Illinois (397)
Indiana (233)
Maryland (645)
Massachusetts (3027)
Michigan (177)
Minnesota (293)
New Jersey (1126)
New York (1100)
North Carolina (761)
Northern California (1713)
Ohio (146)
Pennsylvania (936)
South America (1159)
Southern California (1480)
Texas (565)
Utah (109)
Washington State (408)
707,912 Results for "remedy pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Remedy Pharmaceuticals Receives FDA Guidance to Advance CIRARA for Treatment of Severe Stroke
November 19, 2024
·
1 min read
News
Remedy Pharmaceuticals Announces FDA Orphan Drug Designation Granted for the Treatment of Large Territory Acute Ischemic Stroke with CIRARA
October 22, 2024
·
2 min read
Drug Development
Remedy Pharmaceuticals’ Phase 3 Trial in Large Lesion Stroke Patients Demonstrates Statistically Significant Effect at One Year
October 1, 2024
·
3 min read
Drug Development
Remedy Pharmaceuticals Gets Rights To Acute Stroke Drug Back From Biogen; Announces Clinically Meaningful and Statistically Significant Results From Pre-specified Subgroup and Post Hoc Analyses of Phase 3 Study
Remedy Pharmaceuticals announced that prespecified subgroup analyses from the Phase 3 CHARM clinical trial of CIRARA (IV glibenclamide) showed meaningful improvements in functional outcomes on the modified Rankin Scale (mRS), which were further validated in post hoc analyses.
May 29, 2024
·
4 min read
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing
Pluri Inc. announced that its CDMO division has signed a manufacturing agreement with Remedy Cell Ltd, an innovative, biopharmaceutical company developing stem cell-derived, cell-free therapeutics for complex fibrotic conditions.
March 14, 2024
·
5 min read
Press Releases
Remedy Plan Therapeutics Initiates Dosing in Phase 1 Clinical Trial of RPT1G, a First-In-Class Hyperbolic NAMPT Inhibitor
December 18, 2024
·
2 min read
Press Releases
Remedy Pharmaceuticals Announces Further Analyses from Phase 3 Study Reveals CIRARA Could Significantly Improve Independent Ambulation in Large Hemispheric Infarction Patients
September 3, 2024
·
3 min read
Drug Development
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced the first patient being dosed in DiaMedica’s relaunch of its pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the treatment of acute ischemic stroke.
April 17, 2024
·
7 min read
Press Releases
UPDATE - Remedy Plan Therapeutics Showcases Preclinical Data from First-In-Class NAMPT Inhibitor, RPT1G, Demonstrating Synergy with BCL-2 Family Inhibitors in AML at the 2024 ASH Annual Meeting
December 11, 2024
·
3 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
1 of 70,792
Next
